Cleared Traditional

K131335 - BWMINI EEG

K131335 is the FDA 510(k) clearance for BWMINI EEG by Neurovirtual USA, Inc.. It is a Class 2 Neurology device (product code GWQ) cleared through the Traditional 510(k) pathway after a 635-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
635d
Days
Class 2
Risk

K131335 is an FDA 510(k) clearance for the BWMINI EEG, BWMINIHST, BWMINI PSG. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Neurovirtual USA, Inc. (Doral, US). The FDA issued a Cleared decision on February 3, 2015 after a review of 635 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Neurovirtual USA, Inc. devices

Submission Details

510(k) Number K131335 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2013
Decision Date February 03, 2015
Days to Decision 635 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
487d slower than avg
Panel avg: 148d · This submission: 635d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 88
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K131335.
Natus Quantum
K180181 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Feb 2018
NeuroEEG
K173460 · Memory MD, Inc. · Feb 2018
Micromed BRAIN QUICK system
K171384 · Micromed S.P.A. · Feb 2018
NIHON KOHDEN EEG-1200A WITH JE-120A MULTI CHANNEL ELECTRODE JUNCTION BOX
K113117 · Nihon Kohden America, Inc. · Mar 2012
ENTROPY EASYFIT SENSOR
K103129 · Ge Healthcare · Jul 2011
XLTEK EMU40 EEG HEADBOX, MODEL PK1072
K053386 · Excel Tech. , Ltd. · Apr 2006